Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q3 2023 Earnings

9NovExpected

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-56.25

-37.56

-18.87

-0.18

Details

Expected EPS

-0.84

Actual EPS

-9.34

Surprise EPS

-8.5

Surprise Percent

+1,011.9%

Description

Spyre Therapeutics (SYRE) has reported earnings of -9.34 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.